Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome‐related inflammation and modulating cholesterol transport

Rutaecarpine: A Promising Cardiovascular Protective Alkaloid from Evodia Rutaecarpa (Wu Zhu Yu)

(2019) Kun-ming Tian et al.   PHARMACOLOGICAL RESEARCH

Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis

(2018) Gantsetseg Tumurkhuu et al.   Cell Metabolism

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis

(2018) Alena Grebe et al.   CIRCULATION RESEARCH

PSRC1 overexpression attenuates atherosclerosis progression in apoE −/− mice by modulating cholesterol transportation and inflammation

(2018) Kai Guo et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

(2018) Paul M Ridker et al.   LANCET

Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice

(2018) Delphine Gomez et al.   NATURE MEDICINE

Lipid and Non-lipid Factors Affecting Macrophage Dysfunction and Inflammation in Atherosclerosis

(2018) Mark S. Gibson et al.   Frontiers in Physiology

Monoterpenes modulating cytokines - A review

(2018) Jullyana S.S. Quintans et al.   FOOD AND CHEMICAL TOXICOLOGY

Role of p38 MAPK in Atherosclerosis and Aortic Valve Sclerosis

(2018) Anna Reustle et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Evodiamine prevents dextran sulfate sodium-induced murine experimental colitis via the regulation of NF-κB and NLRP3 inflammasome

(2018) Peng Shen et al.   BIOMEDICINE & PHARMACOTHERAPY

NLRP3 inflammasome: Its regulation and involvement in atherosclerosis

(2017) Zahra Hoseini et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders

(2017) Hua Jiang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Rutaecarpine alleviates renal ischemia reperfusion injury in rats by suppressing the JNK/p38 MAPK signaling pathway and interfering with the oxidative stress response

(2017) Chunhua Wang et al.   Molecular Medicine Reports

Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways

(2016) Xu-qiang Nie et al.   ACTA PHARMACOLOGICA SINICA

Vascular Smooth Muscle Cells in Atherosclerosis

(2016) Martin R. Bennett et al.   CIRCULATION RESEARCH

Hepatic glucose and lipid metabolism

(2016) John G. Jones   DIABETOLOGIA

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis

(2016) Geena Paramel Varghese et al.   Journal of the American Heart Association

Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue

(2016) Faiyaz Ahmad et al.   Scientific Reports

Anti-Inflammatory and Antiatherogenic Effects of the NLRP3 Inflammasome Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet

(2015) A. Abderrazak et al.   CIRCULATION

Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets

(2015) Dipak P. Ramji et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Initiation and perpetuation of NLRP3 inflammasome activation and assembly

(2015) Eric I. Elliott et al.   IMMUNOLOGICAL REVIEWS

A Study of the Geo-Herbalism of Evodiae Fructus Based on a Flow-Injection Mass Spectrometric Fingerprinting Method Combined with Chemometrics

(2015) Yang Zhao et al.   MOLECULES

Inflammasomes: mechanism of action, role in disease and therapeutics

(2015) Haitao Guo et al.   NATURE MEDICINE

Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis

(2015) Barbara Zarzycka et al.   Expert Review of Clinical Pharmacology

Macrophage Functions in Atherosclerosis

(2014) Iris Zeller et al.   CIRCULATION RESEARCH

Rutaecarpine suppresses atherosclerosis in ApoE−/−mice through upregulating ABCA1 and SR-BI within RCT

(2014) Yanni Xu et al.   JOURNAL OF LIPID RESEARCH

Crosstalk of lipids and inflammation in atherosclerosis: the PRO of PGRN?

(2013) Saskia C.A. de Jager et al.   CARDIOVASCULAR RESEARCH

TLR-induced NF-κB activation regulates NLRP3 expression in murine macrophages

(2012) Yu Qiao et al.   FEBS LETTERS

Crosstalk between reverse cholesterol transport and innate immunity

(2012) Kathleen M. Azzam et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Progress and challenges in translating the biology of atherosclerosis

(2011) Peter Libby et al.   NATURE

The Inflammasomes

(2010) Kate Schroder et al.   CELL

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

(2010) Peter Duewell et al.   NATURE

Immune and Inflammatory Mechanisms of Atherosclerosis

(2009) Elena Galkina et al.   Annual Review of Immunology

A Functional Interleukin-1 Receptor Antagonist Polymorphism Influences Atherosclerosis Development

(2009) Peder S Olofsson et al.   CIRCULATION JOURNAL

Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation

(2009) Sook-Kyoung Heo et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression

(2009) F. G. Bauernfeind et al.   JOURNAL OF IMMUNOLOGY